Kerala Ayurveda [KERALAYUR] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison
Kerala Ayurveda
BSE
Loading...
Sun Pharmaceutical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Kerala Ayurveda wins in 4 metrics, Sun Pharmaceutical wins in 15 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Kerala Ayurveda | Sun Pharmaceutical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 617.16 | 37.74 | Sun Pharmaceutical |
| Price-to-Book Ratio | 58.76 | 5.43 | Sun Pharmaceutical |
| Debt-to-Equity Ratio | 548.18 | 3.26 | Sun Pharmaceutical |
| PEG Ratio | 1.28 | -1.94 | Sun Pharmaceutical |
| EV/EBITDA | 823.51 | 23.91 | Sun Pharmaceutical |
| Profit Margin (TTM) | -9.83% | 19.29% | Sun Pharmaceutical |
| Operating Margin (TTM) | 9.54% | 24.34% | Sun Pharmaceutical |
| EBITDA Margin (TTM) | 9.54% | 24.34% | Sun Pharmaceutical |
| Return on Equity | -114.03% | 15.08% | Sun Pharmaceutical |
| Return on Assets (TTM) | -11.42% | 11.87% | Sun Pharmaceutical |
| Free Cash Flow (TTM) | $-84.95M | $119.44B | Sun Pharmaceutical |
| Dividend Yield | N/A | 1.26% | N/A |
| 1-Year Return | 54.87% | -7.54% | Kerala Ayurveda |
| Price-to-Sales Ratio (TTM) | 4.46 | 7.29 | Kerala Ayurveda |
| Enterprise Value | $5.93B | $3,667.83B | Sun Pharmaceutical |
| EV/Revenue Ratio | 4.48 | 6.82 | Kerala Ayurveda |
| Gross Profit Margin (TTM) | 75.65% | 79.58% | Sun Pharmaceutical |
| Revenue per Share (TTM) | $113 | $224 | Sun Pharmaceutical |
| Earnings per Share (Diluted) | $-11.25 | $43.27 | Sun Pharmaceutical |
| Beta (Stock Volatility) | 0.08 | 0.31 | Kerala Ayurveda |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Kerala Ayurveda vs Sun Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Kerala Ayurveda | -2.05% | -4.11% | -13.57% | 22.67% | 47.99% | 12.42% |
| Sun Pharmaceutical | 0.10% | 0.56% | -2.16% | -4.47% | 0.14% | -13.13% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Kerala Ayurveda | 54.87% | 578.17% | 674.37% | 853.76% | 848.27% | 515.64% |
| Sun Pharmaceutical | -7.54% | 86.54% | 195.42% | 85.21% | 825.90% | 2,692.65% |
Performance & Financial Health Analysis: Kerala Ayurveda vs Sun Pharmaceutical
| Metric | KERALAYUR | SUNPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹5.91B | ₹3.92T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 6,185 | 2,090,629 |
| 90 Day Avg. Volume | 25,675 | 2,138,036 |
| Last Close | ₹494.05 | ₹1,641.80 |
| 52 Week Range | ₹250.00 - ₹625.00 | ₹1,553.05 - ₹1,960.35 |
| % from 52W High | -20.95% | -16.25% |
| All-Time High | ₹625.00 (Jul 01, 2025) | ₹1,960.35 (Sep 30, 2024) |
| % from All-Time High | -20.95% | -16.25% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.38% | 0.10% |
| Quarterly Earnings Growth | 5.29% | -0.20% |
| Financial Health | ||
| Profit Margin (TTM) | -0.10% | 0.19% |
| Operating Margin (TTM) | 0.10% | 0.24% |
| Return on Equity (TTM) | -1.14% | 0.15% |
| Debt to Equity (MRQ) | 548.18 | 3.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹8.36 | ₹300.99 |
| Cash per Share (MRQ) | ₹3.27 | ₹108.88 |
| Operating Cash Flow (TTM) | ₹43.75M | ₹110.84B |
| Levered Free Cash Flow (TTM) | ₹-146,991,000 | ₹109.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.26% |
| Last 12-Month Dividend | N/A | ₹21.00 |
Valuation & Enterprise Metrics Analysis: Kerala Ayurveda vs Sun Pharmaceutical
| Metric | KERALAYUR | SUNPHARMA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 617.16 | 37.74 |
| Forward P/E | N/A | 49.97 |
| PEG Ratio | 1.28 | -1.94 |
| Price to Sales (TTM) | 4.46 | 7.29 |
| Price to Book (MRQ) | 58.76 | 5.43 |
| Market Capitalization | ||
| Market Capitalization | ₹5.91B | ₹3.92T |
| Enterprise Value | ₹5.93B | ₹3.67T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.48 | 6.82 |
| Enterprise to EBITDA | 823.51 | 23.91 |
| Risk & Other Metrics | ||
| Beta | 0.08 | 0.31 |
| Book Value per Share (MRQ) | ₹8.36 | ₹300.99 |
Financial Statements Comparison: Kerala Ayurveda vs Sun Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KERALAYUR | SUNPHARMA |
|---|---|---|
| Revenue/Sales | ₹286.12M | ₹137.86B |
| Cost of Goods Sold | ₹69.68M | ₹28.15B |
| Gross Profit | ₹216.44M | ₹109.71B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-58.38M | ₹33.72B |
| EBITDA | ₹52.88M | ₹47.66B |
| Pre-Tax Income | ₹28.11M | ₹31.73B |
| Income Tax | ₹7.83M | ₹8.70B |
| Net Income (Profit) | ₹20.28M | ₹22.93B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KERALAYUR | SUNPHARMA |
|---|---|---|
| Cash & Equivalents | ₹33.89M | ₹102.69B |
| Total Current Assets | ₹407.67M | ₹526.24B |
| Total Current Liabilities | ₹879.75M | ₹181.94B |
| Long-Term Debt | ₹222.20M | ₹3.58B |
| Total Shareholders Equity | ₹128.91M | ₹724.86B |
| Retained Earnings | N/A | ₹578.62B |
| Property, Plant & Equipment | ₹310.45M | ₹100.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KERALAYUR | SUNPHARMA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | KERALAYUR | SUNPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 6,185 | 2,090,629 |
| Average Daily Volume (90 Day) | 25,675 | 2,138,036 |
| Shares Outstanding | 12.03M | 2.40B |
| Float Shares | 8.74M | 1.04B |
| % Held by Insiders | 0.69% | 0.56% |
| % Held by Institutions | 0.00% | 0.25% |
Dividend Analysis & Yield Comparison: Kerala Ayurveda vs Sun Pharmaceutical
| Metric | KERALAYUR | SUNPHARMA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹21.00 |
| Last 12-Month Dividend Yield | N/A | 1.26% |
| 3-Year Avg Annual Dividend | N/A | ₹14.67 |
| 3-Year Avg Dividend Yield | N/A | 0.46% |
| 3-Year Total Dividends | N/A | ₹44.00 |
| Ex-Dividend Date | N/A | Jul 07, 2025 |